ORKA Oruka Therapeutics, Inc.

NASDAQ
$105.35

Oruka Therapeutics, Inc. (ORKA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below ORKA's own trailing one-year pace, with 96% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
56 transactions
Purchases
$0
0 shares
Sales
$13.3M
143,895 shares
Net activity
-$13.3M
purchases less sales

How much of that selling was preplanned? 96% planned / 4% discretionary

10b5-1 plan sales $12.7M 51 transactions · 137,991 shares
Discretionary sales $565.1K 5 transactions · 5,904 shares

Largest single sale: $1.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
BALL KRISTINE M 6 fills Director Sell 10b5-1 18,000 $104.93 $1.9M 16,804 −51.7% of holding
Agarwal Arjun 6 fills Senior Vice President, Finance Sell 10b5-1 10,000 $104.97 $1.0M 23,719 −29.7% of holding
Klein Lawrence Otto 5 fills Chief Executive Officer Sell 10b5-1 25,000 $95.60 $2.4M 941,662 −2.6% of holding
Quinlan Paul T 5 fills General Counsel Sell 10b5-1 9,000 $78.53 $706.7K 38,595 −18.9% of holding
Goncalves Joana 5 fills Chief Medical Officer Sell 10b5-1 7,000 $74.81 $523.6K 35,918 −16.3% of holding
Agarwal Arjun 4 fills Senior Vice President, Finance Sell 10b5-1 9,999 $80.60 $805.9K 18,477 −35.1% of holding
Klein Lawrence Otto 3 fills Chief Executive Officer Sell 10b5-1 25,000 $83.62 $2.1M 931,882 −2.6% of holding
Quinlan Paul T 4 fills General Counsel Sell 10b5-1 10,000 $93.64 $936.4K 37,095 −21.2% of holding
Agarwal Arjun Senior Vice President, Finance Sell 10b5-1 533 $95.75 $51.0K 14,219 −3.6% of holding
Goncalves Joana 4 fills Chief Medical Officer Sell 10b5-1 7,000 $91.93 $643.5K 37,334 −15.8% of holding
Klein Lawrence Otto Chief Executive Officer Sell 2,452 $95.71 $234.7K 923,128 −0.3% of holding
Quinlan Paul T General Counsel Sell 1,039 $95.71 $99.4K 29,995 −3.3% of holding
Goncalves Joana Chief Medical Officer Sell 947 $95.71 $90.6K 31,771 −2.9% of holding
Sandler Laura Lee Chief Operating Officer Sell 906 $95.71 $86.7K 235,478 −0.4% of holding
Agarwal Arjun Senior Vice President, Finance Sell 560 $95.71 $53.6K 14,752 −3.7% of holding
Agarwal Arjun 4 fills Senior Vice President, Finance Sell 10b5-1 9,459 $92.23 $872.4K 21,771 −30.3% of holding
Goncalves Joana 4 fills Chief Medical Officer Sell 10b5-1 7,000 $111.84 $782.9K 38,818 −15.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.